About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | FeNO After Hypoxia in Asthma Patients

FeNO After Hypoxia in Asthma Patients

NCT02391090·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Medical University of Graz

With

Ludwig Boltzmann Institute for Lung Vascular Research

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

stable Asthma (GINA 1-2)

You may not be if

autoimmune disease
unstable Asthma (GINA 3-4)
history of pneumonia/fever within 3 months
place of residence \>1000m above sea level
trip/vacation above \>2500m within 4 weeks
cystic fibrosis
diabetes mellitus
immunodeficiency
atopic dermatitis
ciliary dyskinesia
pregnancy
chronic obstructive pulmonary disease
history of smoking (\>1py)
immunosuppression / systemic corticosteroids within 3 months
cardiovascular diseases
interstitial lung disease
bronchopulmonary dysplasia

The record

StatusCompleted

PhaseNo phase

Taking part21

StartedNov 2014

UpdatedMar 18, 2015

Conditions

Where1

Medical University of Graz
Graz, Styria, Austria